Literature DB >> 14667586

Lung resection for non-small-cell lung cancer in patients older than 70: mortality, morbidity, and late survival compared with the general population.

Ozcan Birim1, H Mischa Zuydendorp, Alexander P W M Maat, A Pieter Kappetein, Marinus J C Eijkemans, Ad J J C Bogers.   

Abstract

BACKGROUND: Operative mortality and morbidity in elderly patients operated on for non-small-cell lung cancer are acceptable. However, risk factors for hospital mortality and the benefits for the patients in the long term are insufficiently defined, and survival compared with the general population is not known.
METHODS: From January 1989 to October 2001, 126 consecutive patients older than 70 years of age underwent resection for non-small-cell lung cancer. Each patient was scaled according to the Charlson Comorbidity Index. Postoperative events were divided into minor and major complications. Risk factors for complications and long-term survival were assessed by univariate and multivariate logistic regression analysis. Survival was compared with the yearly expected survival rates of the general population.
RESULTS: The hospital mortality was 3.2%. Minor complications occurred in 71 (57%) patients, major complications, in 16 (13%) patients. No risk factor was predictive for major complications. However, a Charlson comorbidity grade of 3 to 4 was predictive for major complications (odds ratio, 12.6; 95% confidence interval, 1.5 to 108.6). Our study showed a 5- and 10-year survival rate of 37% (95% confidence interval, 23 to 51) and 15% (95% confidence interval, 8 to 22). Smoking (odds ratio, 2.3), chronic obstructive pulmonary disease (odds ratio, 2.1), and pathologic stage IIIA (odds ratio, 2.2) or IIIB (odds ratio, 11.9) were risk factors for long-term survival. The observed survival was lower than the expected survival, but the difference decreased with increasing time after pulmonary resection.
CONCLUSIONS: Pulmonary resection for non-small-cell lung cancer in patients older than 70 years shows acceptable morbidity and mortality. The Charlson index is a better predictor of complications than individual risk factors. In time survival is no longer correlated with the disease but follows the same pattern as the general population.

Entities:  

Mesh:

Year:  2003        PMID: 14667586     DOI: 10.1016/s0003-4975(03)01064-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  18 in total

1.  [Preoperative evaluation and risk estimation in thoracic surgery].

Authors:  H Mutlak; S Czerner; H Winter; B Zwissler; P Lackermeier
Journal:  Anaesthesist       Date:  2010-10       Impact factor: 1.041

2.  Risk factors for postoperative complications after lung resection for non-small cell lung cancer in elderly patients at a single institution in China.

Authors:  Guotian Pei; Shijie Zhou; Yi Han; Zhidong Liu; Shaofa Xu
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

3.  Significance of pretreatment comorbidities in elderly patients with advanced non-small-cell lung cancer treated with chemotherapy or epidermal growth factor receptor-tyrosine kinase inhibitor.

Authors:  Kaoru Irisa; Katsuhiro Masago; Yosuke Togashi; Shiro Fujita; Yukimasa Hatachi; Akiko Fukuhara; Yuichi Sakamori; Yung Hak Kim; Tadashi Mio; Michiaki Mishima
Journal:  Med Oncol       Date:  2010-12-07       Impact factor: 3.064

4.  Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis.

Authors:  Julia Kravchenko; Mark Berry; Konstantin Arbeev; H Kim Lyerly; Anatoly Yashin; Igor Akushevich
Journal:  Lung Cancer       Date:  2015-01-17       Impact factor: 5.705

Review 5.  [Thoracic surgery in the elderly].

Authors:  H Dienemann; H Hoffmann; F Herth
Journal:  Chirurg       Date:  2005-02       Impact factor: 0.955

6.  Impact of mediastinal lymph node dissection on octogenarians with non-small cell lung cancer.

Authors:  Shinjiro Mizuguchi; Kiyotoshi Inoue; Takashi Iwata; Nobuhiro Izumi; Takuma Tsukioka; Ryuhei Morita; Tatsuya Nishida; Noritoshi Nishiyama; Taichi Shuto; Shigefumi Suehiro
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-03

7.  Outcomes of lung cancer surgery in patients with coronary artery disease: a decade of experience at a single institution.

Authors:  Ryu Kanzaki; Masayoshi Inoue; Masato Minami; Yasushi Shintani; Soichiro Funaki; Tomohiro Kawamura; Meinoshin Okumura
Journal:  Surg Today       Date:  2016-05-19       Impact factor: 2.549

8.  Gene expression profiles from needle biopsies provide useful signatures of non-small cell lung carcinomas.

Authors:  Douglas E Paull; Kevin Kelley; Jazbieh Moezzi; Madhavi Kadakia; Steven J Berberich
Journal:  Biomark Insights       Date:  2007-06-08

9.  Video-assisted thoracic surgery lobectomy reduces the morbidity after surgery for stage I non-small cell lung cancer.

Authors:  Masashi Muraoka; Tadayuki Oka; Shinji Akamine; Tsutomu Tagawa; Akihiro Nakamura; Satoshi Hashizume; Keitaro Matsumoto; Masato Araki; Yutaka Tagawa; Takeshi Nagayasu
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-02

10.  Management and postoperative outcome in primary lung cancer and heart disease co-morbidity: a systematic review and meta-analysis.

Authors:  George D Bablekos; Antonis Analitis; Stylianos A Michaelides; Konstantinos A Charalabopoulos; Anastasia Tzonou
Journal:  Ann Transl Med       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.